The offering provides near-term cash but at significant dilution and with a large warrant overhang. Monitor the October 30 PDUFA date for INO-3107 and any updates on cash runway. The stock may face continued pressure from the overhang of 48.4M exercisable warrants at $1.10.
Price Chart
Executive Summary
Inovio Pharmaceuticals priced a $20M public offering of 21M shares and warrants for 42M shares (or pre-funded warrants) at $0.95/unit, with net proceeds of ~$18.3M. The underwriter exercised an option for additional warrants covering 6.3M shares. This dilutive capital raise follows a prior going-concern disclosure and adds ~30% immediate dilution plus significant warrant overhang, reinforcing the bearish outlook.
Key Financial Metrics
Key Facts
- Offering of 21,052,632 shares and warrants to purchase up to 42,105,264 shares at $0.95/unit
- Underwriter exercised option for warrants to purchase an additional 6,315,788 shares
- Net proceeds expected to be approximately $18.3 million
- Warrants have a $1.10 exercise price, 5-year term, with beneficial ownership limitations
- Offering priced at ~8% discount to the prior close of $1.03
- Company previously disclosed going-concern risk in the related 424B5 filing
Financial Impact
Immediate dilution of ~30% from shares alone; potential further dilution from warrants (up to 48.4M additional shares if exercised). Net cash infusion of ~$18.3M against an $86M market cap.
Risk Factors
- Substantial dilution from shares and warrants
- Going-concern risk as previously disclosed
- Warrant overhang may cap upside
- Dependence on INO-3107 regulatory outcome
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-326785 |
| Document: d253972dex42.htm | 0001193125-26-326785 |
| Document: d253972dex41.htm | 0001193125-26-326785 |
| Document: d253972d8k.htm | 0001193125-26-326785 |
| Document: d253972dex51.htm | 0001193125-26-326785 |
| Document: d253972dex992.htm | 0001193125-26-326785 |
| Document: d253972dex991.htm | 0001193125-26-326785 |
| Document: 0001193125-26-326785-index-headers.html | 0001193125-26-326785 |
| Document: 0001193125-26-326785-index.html | 0001193125-26-326785 |
| Document: 0001193125-26-326785.txt | 0001193125-26-326785 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 31, 2026 9w ago | 8-K | $0.6770 $1.29 | ▼ −90.55% | ▼ −87.56% | $1.18 (−75.04%) |
Jul 30, 2026 9w ago | 424B5 | $0.6770 $1.29 | ▼ −90.55% | ▼ −87.56% | $1.18 (−75.04%) |
Jul 30, 2026 9w ago | Press Release | $0.6560 $1.26 | ▼ −92.07% | ▼ −88.11% | $1.18 (−80.64%) |
Jul 13, 2026 11w ago | EFFECT | $1.16 $0.7364 | ▲ +36.52% | ▲ +39.70% | $1.18 (−2.16%) |
Jul 2, 2026 13w ago | S-3 | $1.22 $0.6560 | ▲ +46.23% | ▲ +45.81% | $1.18 (+2.87%) |
Jun 11, 2026 16w ago | Institutional Cluster | $1.10 $1.19 | ▲ +8.18% | ▲ +6.29% | $1.18 (+7.73%) |
Apr 6, 2026 25w ago | 8-K | $1.13 $1.14 | ▼ −0.89% | ▲ +8.10% | $1.18 (−4.87%) |
Apr 2, 2026 26w ago | 424B5 | $1.13 $1.12 | ▲ +0.89% | ▲ +10.76% | $1.18 (−4.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access